Glenmede Trust’s Dynavax Technologies DVAX Stock Holding History

Glenmede Trust’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,162,249	Closed	-$17.9M	–	1497
2025 Q4	$17.9M	Buy	+1,162,249	New	+$12.8M	0.08%	202
2025 Q1	$13.6M	Sell	1,050,934 -35,331	-3%	-$468K	0.07%	276
2024 Q4	$13.9M	Sell	1,086,265 -7,307	-0.7%	-$88.4K	0.07%	299
2024 Q3	$12.2M	Sell	1,093,572 -16,451	-1%	-$181K	0.06%	333
2024 Q2	$12.5M	Buy	1,110,023 +547,544	+97%	+$6.37M	0.06%	319
2024 Q1	$6.98M	Buy	+562,479	New	+$7.34M	0.04%	395

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust's DVAX Position: Q1 2026 in Review

Glenmede Trust sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,162,249 shares — an estimated $17.9M sold.

Glenmede Trust first reported a position in DVAX in Q1 2024 and held it in 6 quarters. The position peaked at $17.9M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Glenmede Trust reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Glenmede Trust sold 1,162,249 Dynavax Technologies shares in Q1 2026, an estimated $17.9M.
Glenmede Trust first reported a position in Dynavax Technologies in Q1 2024 and held it in 6 quarters.
Glenmede Trust's Dynavax Technologies position peaked at $17.9M in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.